Vanguard Group’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Sell |
1,689,351
-247,640
| -13% | -$287K | ﹤0.01% | 3537 |
|
|
2025
Q1 | $2.13M | Sell |
1,936,991
-3,780
| -0.2% | -$4.16K | ﹤0.01% | 3475 |
|
|
2024
Q4 | $3.34M | Buy |
1,940,771
+6,732
| +0.3% | +$11.6K | ﹤0.01% | 3410 |
|
|
2024
Q3 | $4.8M | Buy |
1,934,039
+37,090
| +2% | +$92K | ﹤0.01% | 3286 |
|
|
2024
Q2 | $4.59M | Buy |
1,896,949
+231,891
| +14% | +$561K | ﹤0.01% | 3295 |
|
|
2024
Q1 | $6.74M | Sell |
1,665,058
-174,494
| -9% | -$707K | ﹤0.01% | 3169 |
|
|
2023
Q4 | $7.06M | Sell |
1,839,552
-17,000
| -0.9% | -$65.3K | ﹤0.01% | 3138 |
|
|
2023
Q3 | $7.7M | Buy |
1,856,552
+1,121,700
| +153% | +$4.66M | ﹤0.01% | 3045 |
|
|
2023
Q2 | $3.53M | Buy |
734,852
+115
| +0% | +$553 | ﹤0.01% | 3462 |
|
|
2023
Q1 | $2.98M | Buy |
734,737
+18,900
| +3% | +$76.7K | ﹤0.01% | 3528 |
|
|
2022
Q4 | $3.87M | Buy |
715,837
+64,791
| +10% | +$350K | ﹤0.01% | 3427 |
|
|
2022
Q3 | $6.53M | Buy |
651,046
+15,267
| +2% | +$153K | ﹤0.01% | 3173 |
|
|
2022
Q2 | $2.99M | Sell |
635,779
-598,992
| -49% | -$2.82M | ﹤0.01% | 3629 |
|
|
2022
Q1 | $4.83M | Buy |
1,234,771
+679,798
| +122% | +$2.66M | ﹤0.01% | 3547 |
|
|
2021
Q4 | $3.75M | Sell |
554,973
-769,925
| -58% | -$5.21M | ﹤0.01% | 3773 |
|
|
2021
Q3 | $19.7M | Buy |
+1,324,898
| New | +$19.7M | ﹤0.01% | 2873 |
|